Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular and Clinical Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9450 Online ISSN: 2049-9469
Journal Cover
November-2021 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2021 Volume 15 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence

  • Authors:
    • Ryoji Iwamoto
    • Shuichi Tanoue
    • Shuji Nagata
    • Kazuhiro Tabata
    • Junya Fukuoka
    • Masamichi Koganemaru
    • Akiko Sumi
    • Tomonori Chikasue
    • Toshi Abe
    • Daigo Murakami
    • Shinzo Takamori
    • Hidenobu Ishii
    • Koichi Ohshima
    • Shoichiro Ohta
    • Kenji Izuhara
    • Kiminori Fujimoto
  • View Affiliations / Copyright

    Affiliations: Department of Radiology, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan, Department of Pathology, Nagasaki Graduate School of Biomedical Sciences, Nagasaki 852‑8523, Japan, Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan, Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan, Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka 830‑0011, Japan, Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga 849‑8501, Japan
    Copyright: © Iwamoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 228
    |
    Published online on: September 10, 2021
       https://doi.org/10.3892/mco.2021.2391
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Adenocarcinoma is the most common histological type of non‑small cell lung cancer (NSCLC), and various biomarkers for predicting its prognosis after surgical resection have been suggested, particularly in early‑stage lung adenocarcinoma. Periostin (also referred to as POSTN, PN or osteoblast‑specific factor) is an extracellular matrix protein, the expression of which is associated with tumor invasiveness in patients with NSCLC. In the present study, the novel approach, in which the thin‑section CT findings prior to surgical resection and periostin expression of resected specimens were analyzed in combination, was undertaken to assess whether the findings could be a biomarker for predicting the outcomes following resection of T1 invasive lung adenocarcinoma. A total of 73 patients who underwent surgical resection between January 2000 and December 2009 were enrolled. A total of seven parameters were assessed in the thin‑section CT scans: i) Contour; ii) part‑solid ground‑glass nodule or solid nodule; iii) percentage of solid component (the CT solid score); iv) presence of air‑bronchogram and/or bubble‑like lucencies; v) number of involved vessels; vi) shape linear strands between the nodule and the visceral pleura; and vii) number of linear strands between the nodule and the visceral pleura. Two chest radiologists independently assessed the parameters. Periostin expression was evaluated on the basis of the strength and extent of staining. Univariate and multivariate analyses were subsequently performed using the Cox proportional hazards model. There was a substantial to almost perfect agreement between the two observers with regard to classification of the seven thin‑section CT parameters (κ=0.64‑0.85). In the univariate analysis, a CT solid score >80%, pathological lymphatic invasion, tumor and lymph node status and high periostin expression were significantly associated with recurrence (all P<0.05). Multivariate analysis demonstrated that a CT solid score >80% and high periostin expression were risk factors for recurrence (P=0.002 and P=0.011, respectively). The cumulative recurrence rates among the three groups (both negative, CT solid score >80% or high periostin expression, or both positive) were significantly different (log‑rank test, P<0.001). Although the solid component is already known to be a major predictor of outcome in lung adenocarcinomas according to previous studies, the combined analysis of CT solid score and periostin expression might predict the likelihood of tumor recurrence more precisely.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Lewis DR, Check DP, Caporaso NE, Travis WD and Devesa SS: US lung cancer trends by histologic type. Cancer. 120:2883–2892. 2014.PubMed/NCBI View Article : Google Scholar

2 

Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, et al: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 6:244–285. 2011.PubMed/NCBI View Article : Google Scholar

3 

Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, Park BJ, Rusch VW and Travis WD: Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 Stage Ⅰ cases. Mod Pathol. 24:653–664. 2011.PubMed/NCBI View Article : Google Scholar

4 

Lee HY, Jeong JY, Lee KS, Kim HJ, Han J, Kim BT, Kim J, Shim YM, Kim JH and Song I: Solitary pulmonary nodular lung adenocarcinoma: Correlation of histopathologic scoring and patient survival with imaging biomarkers. Radiology. 264:884–893. 2012.PubMed/NCBI View Article : Google Scholar

5 

Kadota K, Villena-Vargas J, Yoshizawa A, Motoi N, Sima CS, Riely GJ, Rusch VW, Adusumilli PS and Travis WD: Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol. 38:448–460. 2014.PubMed/NCBI View Article : Google Scholar

6 

Edge SB and Compton CC: The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.PubMed/NCBI View Article : Google Scholar

7 

Chae HD, Park CM, Park SJ, Lee SM, Kim KG and Goo JM: Computerized texture analysis of persistent part-solid ground-glass nodules: Differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas. Radiology. 273:285–293. 2014.PubMed/NCBI View Article : Google Scholar

8 

Heidinger BH, Anderson KR, Nemec U, Costa DB, Gangadharan SP, VanderLaan PA and Bankier AA: Lung adenocarcinoma manifesting as pure ground-glass nodules: Correlating CT size, volume, density, and roundness with histopathologic invasion and size. J Thorac Oncol. 12:1288–1298. 2017.PubMed/NCBI View Article : Google Scholar

9 

Takeshita S, Kikuno R, Tezuka K and Amann E: Osteoblast-specific factor 2: Cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J. 294:271–278. 1993.PubMed/NCBI View Article : Google Scholar

10 

Kudo Y, Siriwardena BS, Hatano H, Ogawa I and Takata T: Periostin: Novel diagnostic and therapeutic target for cancer. Histol histopathol. 22:1167–1174. 2007.PubMed/NCBI View Article : Google Scholar

11 

Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, Fujimoto K, Ohshima K, Shiraishi H, Uchida M, Ono J, et al: Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J. 37:1119–1127. 2011.PubMed/NCBI View Article : Google Scholar

12 

Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CT and Kudo A: The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 71:1279–1288. 2014.PubMed/NCBI View Article : Google Scholar

13 

Ruan K, Bao S and Ouyang G: The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci. 66:2219–2230. 2009.PubMed/NCBI View Article : Google Scholar

14 

Sasaki H, Dai M, Auclair D, Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y and Chen LB: Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients. Cancer Lett. 172:37–42. 2001.PubMed/NCBI View Article : Google Scholar

15 

Sasaki H, Dai M, Auclair D, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y and Chen LB: Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer. 92:843–848. 2001.PubMed/NCBI View Article : Google Scholar

16 

Fujimoto K, Kawaguchi T, Nakashima O, Ono J, Ohta S, Kawaguchi A, Tonan T, Ohshima K, Yano H, Hayabuchi N, et al: Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep. 25:1211–1216. 2011.PubMed/NCBI View Article : Google Scholar

17 

Kudo Y, Ogawa I, Kitajima S, Kitagawa M, Kawai H, Gaffney PM, Miyauchi M and Takata T: Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 66:6928–6935. 2006.PubMed/NCBI View Article : Google Scholar

18 

Fukushima N, Kikuchi Y, Nishiyama T, kudo A and Fukayama M: Periostin deposition in the stroma of invasive and intraductal neoplasms of the pancreas. Modern Pathol. 21:1044–1053. 2008.PubMed/NCBI View Article : Google Scholar

19 

Hong LZ, Wei XW, Chen JF and Shi Y: Overexpression of periostin predicts poor prognosis in non-small cell lung cancer. Oncol Let. 6:1595–1603. 2013.PubMed/NCBI View Article : Google Scholar

20 

Kim EA, Johkoh T, Lee KS, Han J, Fujimoto K, Sadohara J, Yang PS, Kozuka T, Honda O and Kim S: Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: Pathologic and prognostic implications. Am J Roentgenol. 177:1417–1422. 2001.PubMed/NCBI View Article : Google Scholar

21 

Maeyashiki T, Suzuki K, Hattori A, Matsunaga T, Takamochi K and Oh S: The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumor dimension in resectable lung cancer. Eur J Cardiothorac Surg. 43:915–918. 2013.PubMed/NCBI View Article : Google Scholar

22 

Burt BM, Leung AN, Yanagawa M, Chen W, Groth SS, Hoang CD, Nair VS and Shrager JB: Diameter of solid tumor component alone should be used to establish T stage in lung adenocarcinoma. Ann Surg Oncol. 22 (Suppl 3):S1318–S1323. 2015.PubMed/NCBI View Article : Google Scholar

23 

Shikuma K, Menju T, Chen F, Kubo T, Muro S, Sumiyoshi S, Ohata K, Sowa T, Nakanishi T, Cho H, et al: Is volumetric 3-dimensional computed tomography useful to predict histological tumor invasiveness? Analysis of 211 lesions of cT1N0M0 lung adenocarcinoma. Interact Cardiovasc Thorac Surg. 22:831–838. 2016.PubMed/NCBI View Article : Google Scholar

24 

Hattori A, Matsunaga T, Hayashi T, Takamochi K, Oh S and Suzuki K: Prognostic impact of the findings on thin-section computed tomography in patients with subcentimeter non-small cell lung cancer. J Thorac Oncol. 12:954–962. 2017.PubMed/NCBI View Article : Google Scholar

25 

International Association for the Study of Lung Cancer: Staging Manual in Thoracic Oncology. 2nd edition. Editorial Rx Press, North Fort Myers, FL, 2016.

26 

Ginsberg RJ and Rubinstein LV: Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thoracic Surg. 60:615–623. 1995.PubMed/NCBI View Article : Google Scholar

27 

Bankier AA, MacMahon H, Goo JM, Rubin GD, Schaefer-Prokop CM and Naidich DP: Recommendations for measuring pulmonary nodules at CT: A statement from the Fleischner Society. Radiology. 285:584–600. 2017.PubMed/NCBI View Article : Google Scholar

28 

Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL and Remy J: Fleischner society: Glossary of terms for thoracic imaging. Radiology. 246:697–722. 2008.PubMed/NCBI View Article : Google Scholar

29 

Zwirewich CV, Vedal S, Miller RR and Müller NL: Solitary pulmonary nodule: High-resolution CT and radiologic-pathologic correlation. Radiology. 179:469–476. 1991.PubMed/NCBI View Article : Google Scholar

30 

Li M, Wang Y, Chen Y and Zhang Z: Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules. J Cardiothorac Surg. 13(9)2018.PubMed/NCBI View Article : Google Scholar

31 

Kundel HL and Polansky M: Measurement of observer agreement. Radiology. 228:303–308. 2003.PubMed/NCBI View Article : Google Scholar

32 

Miao Y, Zhang J, Zou J, Zhu Q, Lv T and Song Y: Correlation in histological subtypes with high resolution computed tomography signatures of early stage lung adenocarcinoma. Transl Lung Cancer Res. 6:14–22. 2017.PubMed/NCBI View Article : Google Scholar

33 

Asamura H, Hishida T, Suzuki K, Koike T, Nakamura K, Kusumoto M, Nagai K, Tada H, Mitsudomi T, Tsuboi M, et al: Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan clinical oncology group 0201. J Thorac Cardiovasc Surg. 146:24–30. 2013.PubMed/NCBI View Article : Google Scholar

34 

Murakami D, Takamori S, Kawahara A, Mitsuoka M, Kashihara M, Yoshiyama K, Matsumoto R, Yokoyama S, Fujimoto K, Kawaguchi A, et al: Periostin expression in non-small cell lung cancer: Clinical significance. Kurume Med J. 64:13–20. 2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Iwamoto R, Tanoue S, Nagata S, Tabata K, Fukuoka J, Koganemaru M, Sumi A, Chikasue T, Abe T, Murakami D, Murakami D, et al: T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence. Mol Clin Oncol 15: 228, 2021.
APA
Iwamoto, R., Tanoue, S., Nagata, S., Tabata, K., Fukuoka, J., Koganemaru, M. ... Fujimoto, K. (2021). T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence. Molecular and Clinical Oncology, 15, 228. https://doi.org/10.3892/mco.2021.2391
MLA
Iwamoto, R., Tanoue, S., Nagata, S., Tabata, K., Fukuoka, J., Koganemaru, M., Sumi, A., Chikasue, T., Abe, T., Murakami, D., Takamori, S., Ishii, H., Ohshima, K., Ohta, S., Izuhara, K., Fujimoto, K."T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence". Molecular and Clinical Oncology 15.5 (2021): 228.
Chicago
Iwamoto, R., Tanoue, S., Nagata, S., Tabata, K., Fukuoka, J., Koganemaru, M., Sumi, A., Chikasue, T., Abe, T., Murakami, D., Takamori, S., Ishii, H., Ohshima, K., Ohta, S., Izuhara, K., Fujimoto, K."T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence". Molecular and Clinical Oncology 15, no. 5 (2021): 228. https://doi.org/10.3892/mco.2021.2391
Copy and paste a formatted citation
x
Spandidos Publications style
Iwamoto R, Tanoue S, Nagata S, Tabata K, Fukuoka J, Koganemaru M, Sumi A, Chikasue T, Abe T, Murakami D, Murakami D, et al: T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence. Mol Clin Oncol 15: 228, 2021.
APA
Iwamoto, R., Tanoue, S., Nagata, S., Tabata, K., Fukuoka, J., Koganemaru, M. ... Fujimoto, K. (2021). T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence. Molecular and Clinical Oncology, 15, 228. https://doi.org/10.3892/mco.2021.2391
MLA
Iwamoto, R., Tanoue, S., Nagata, S., Tabata, K., Fukuoka, J., Koganemaru, M., Sumi, A., Chikasue, T., Abe, T., Murakami, D., Takamori, S., Ishii, H., Ohshima, K., Ohta, S., Izuhara, K., Fujimoto, K."T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence". Molecular and Clinical Oncology 15.5 (2021): 228.
Chicago
Iwamoto, R., Tanoue, S., Nagata, S., Tabata, K., Fukuoka, J., Koganemaru, M., Sumi, A., Chikasue, T., Abe, T., Murakami, D., Takamori, S., Ishii, H., Ohshima, K., Ohta, S., Izuhara, K., Fujimoto, K."T1 invasive lung adenocarcinoma: Thin‑section CT solid score and histological periostin expression predict tumor recurrence". Molecular and Clinical Oncology 15, no. 5 (2021): 228. https://doi.org/10.3892/mco.2021.2391
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team